Phase II Safety Study of Palbociclib in Combination With Letrozole or Fulvestrant in African American Women With Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
Phase of Trial: Phase II/III
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Palbociclib (Primary) ; Fulvestrant; Letrozole
- Indications Advanced breast cancer
- Focus Adverse reactions
- Acronyms PALINA
- 12 Oct 2017 Planned End Date changed from 1 Jun 2018 to 1 Dec 2019.
- 12 Oct 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
- 11 Jul 2016 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018.